Submit Biologics License Application for AMT-130
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 29 Jul 2025
- Due
- 31 Mar 2026
- Checked
- 1 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“planned Biologics License Application (BLA) submission for AMT-130 in the first quarter of 2026”
What we found
Evidence strength A What the grades mean
The company did not submit the BLA in the first quarter of 2026 as planned, subsequently announcing a revised plan to submit the application in the third quarter of 2026.
-
A uniQure N.V. 8-K filed 2026-06-17
“Company intends to submit the BLA in third quarter of 2026” ✓ confirmed on the page
Market reaction: the shares moved +65.0% against the S&P 500 over the three sessions around the disclosure (16 Jun 2026 to 22 Jun 2026). What this measures
Checked 1 Oct 2026.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- 1 versions
-
Version 1 · original · stated 29 Jul 2025
Deadline 31 Mar 2026 (“in the first quarter of 2026”) · wording expected
-
Version 2 · stated 17 Jun 2026
Deadline 30 Sep 2026 (“in the third quarter of 2026”) · wording aspirational
“The Company intends to submit the BLA in the third quarter of 2026.”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory submission
- Indicative materiality
- High rules
- Action
- Submit
- Deliverable
- Biologics License Application for AMT-130
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to regulatory alignment
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-QURE-001916 · Corrections policy